Annual Retained Earnings
-$319.97 M
-$15.84 M-5.21%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual retained earnings is -$319.97 million, with the most recent change of -$15.84 million (-5.21%) on June 30, 2024.
- During the last 3 years, AYTU annual retained earnings has fallen by -$141.67 million (-79.46%).
- AYTU annual retained earnings is now -63994500.00% below its all-time high of -$500.00, reached on August 31, 2009.
Performance
AYTU Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$318.50 M
+$1.47 M+0.46%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly retained earnings is -$318.50 million, with the most recent change of +$1.47 million (+0.46%) on September 30, 2024.
- Over the past year, AYTU quarterly retained earnings has dropped by -$6.25 million (-2.00%).
- AYTU quarterly retained earnings is now -63699700.00% below its all-time high of -$500.00, reached on August 31, 2009.
Performance
AYTU Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AYTU Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.2% | -2.0% |
| 3 y3 years | -79.5% | -54.5% |
| 5 y5 years | -200.8% | -99.9% |
AYTU Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.5% | at low | -46.3% | +0.5% |
| 5 y | 5-year | -200.8% | at low | -185.6% | +0.5% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +0.5% |
Aytu BioPharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$318.50 M(-0.5%) |
| Jun 2024 | -$319.97 M(+5.2%) | -$319.97 M(+1.5%) |
| Mar 2024 | - | -$315.36 M(+0.9%) |
| Dec 2023 | - | -$312.47 M(+0.1%) |
| Sep 2023 | - | -$312.25 M(+2.7%) |
| Jun 2023 | -$304.13 M(+5.9%) | -$304.13 M(+0.8%) |
| Mar 2023 | - | -$301.67 M(+2.4%) |
| Dec 2022 | - | -$294.47 M(+1.1%) |
| Sep 2022 | - | -$291.35 M(+1.5%) |
| Jun 2022 | -$287.08 M(+61.0%) | -$287.08 M(+6.0%) |
| Mar 2022 | - | -$270.77 M(+24.4%) |
| Dec 2021 | - | -$217.70 M(+5.6%) |
| Sep 2021 | - | -$206.15 M(+15.6%) |
| Jun 2021 | -$178.30 M(+48.6%) | -$178.30 M(+11.9%) |
| Mar 2021 | - | -$159.30 M(+19.0%) |
| Dec 2020 | - | -$133.84 M(+7.7%) |
| Sep 2020 | - | -$124.32 M(+3.6%) |
| Jun 2020 | -$120.01 M(+12.8%) | -$120.01 M(+2.7%) |
| Mar 2020 | - | -$116.87 M(+4.8%) |
| Dec 2019 | - | -$111.53 M(+0.2%) |
| Sep 2019 | - | -$111.32 M(+4.6%) |
| Jun 2019 | -$106.39 M(+34.2%) | -$106.39 M(+15.8%) |
| Mar 2019 | - | -$91.86 M(+5.1%) |
| Dec 2018 | - | -$87.36 M(+5.6%) |
| Sep 2018 | - | -$82.70 M(+4.3%) |
| Jun 2018 | -$79.26 M(+14.8%) | -$79.26 M(-0.7%) |
| Mar 2018 | - | -$79.81 M(+3.7%) |
| Dec 2017 | - | -$76.99 M(+5.0%) |
| Sep 2017 | - | -$73.31 M(+6.1%) |
| Jun 2017 | -$69.07 M(+48.3%) | -$69.07 M(+10.8%) |
| Mar 2017 | - | -$62.32 M(+9.1%) |
| Dec 2016 | - | -$57.10 M(+9.2%) |
| Sep 2016 | - | -$52.29 M(+12.3%) |
| Jun 2016 | -$46.56 M | -$46.56 M(+48.9%) |
| Mar 2016 | - | -$31.26 M(+30.3%) |
| Dec 2015 | - | -$23.99 M(+16.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -$20.66 M(+12.4%) |
| Jun 2015 | -$18.38 M(+2815.8%) | -$18.38 M(+45.8%) |
| Mar 2015 | - | -$12.61 M(+1821.9%) |
| Feb 2015 | - | -$656.10 K(+1.5%) |
| Nov 2014 | - | -$646.20 K(+2.5%) |
| Aug 2014 | -$630.40 K(-94.1%) | -$630.40 K(+1.8%) |
| Jun 2014 | -$10.66 M(+1774.1%) | - |
| May 2014 | - | -$619.20 K(+1.9%) |
| Feb 2014 | - | -$607.40 K(+3.8%) |
| Nov 2013 | - | -$585.20 K(+2.9%) |
| Aug 2013 | -$568.70 K(+11.2%) | -$568.70 K(+1.9%) |
| May 2013 | - | -$558.20 K(+2.4%) |
| Feb 2013 | - | -$544.90 K(>+9900.0%) |
| Nov 2012 | - | -$500.00(-99.9%) |
| Aug 2012 | -$511.40 K(>+9900.0%) | -$511.40 K(>+9900.0%) |
| May 2012 | - | -$500.00(0.0%) |
| Feb 2012 | - | -$500.00(0.0%) |
| Nov 2011 | - | -$500.00(0.0%) |
| Aug 2011 | -$500.00(0.0%) | -$500.00(-99.9%) |
| May 2011 | - | -$380.20 K(+5.8%) |
| Feb 2011 | - | -$359.50 K(+8.1%) |
| Nov 2010 | - | -$332.60 K(>+9900.0%) |
| Aug 2010 | -$500.00(0.0%) | -$500.00(-99.8%) |
| May 2010 | - | -$300.80 K(+5.2%) |
| Feb 2010 | - | -$285.90 K(+4.5%) |
| Nov 2009 | - | -$273.70 K(>+9900.0%) |
| Aug 2009 | -$500.00(-99.7%) | -$500.00(-99.8%) |
| May 2009 | - | -$243.40 K(+4.1%) |
| Feb 2009 | - | -$233.90 K(+7.3%) |
| Nov 2008 | - | -$218.00 K(+11.7%) |
| Aug 2008 | -$195.20 K(+40.8%) | -$195.20 K(+6.4%) |
| May 2008 | - | -$183.40 K(+10.8%) |
| Feb 2008 | - | -$165.50 K(+7.3%) |
| Nov 2007 | - | -$154.30 K(+11.3%) |
| Aug 2007 | -$138.60 K | -$138.60 K(+9.2%) |
| May 2007 | - | -$126.90 K |
FAQ
- What is Aytu BioPharma annual retained earnings?
- What is the all time high annual retained earnings for Aytu BioPharma?
- What is Aytu BioPharma annual retained earnings year-on-year change?
- What is Aytu BioPharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Aytu BioPharma?
- What is Aytu BioPharma quarterly retained earnings year-on-year change?
What is Aytu BioPharma annual retained earnings?
The current annual retained earnings of AYTU is -$319.97 M
What is the all time high annual retained earnings for Aytu BioPharma?
Aytu BioPharma all-time high annual retained earnings is -$500.00
What is Aytu BioPharma annual retained earnings year-on-year change?
Over the past year, AYTU annual retained earnings has changed by -$15.84 M (-5.21%)
What is Aytu BioPharma quarterly retained earnings?
The current quarterly retained earnings of AYTU is -$318.50 M
What is the all time high quarterly retained earnings for Aytu BioPharma?
Aytu BioPharma all-time high quarterly retained earnings is -$500.00
What is Aytu BioPharma quarterly retained earnings year-on-year change?
Over the past year, AYTU quarterly retained earnings has changed by -$6.25 M (-2.00%)